PWR
68
-4
INTU
66
3
VIX
32
13
AMGN
59
12
NWSA
80
-4
ETN
75
-4
NDAQ
46
4
ABT
57
7
MKC
33
-2
XEL
50
2
AVGO
69
-7
APH
68
-5
CINF
48
3
DOW
38
-2
JCI
33
-2
WRK
65
7
THC
70
-2
KO
49
-3
CPB
40
-2
AEE
37
4
PWR
68
-4
INTU
66
3
VIX
32
13
AMGN
59
12
NWSA
80
-4
ETN
75
-4
NDAQ
46
4
ABT
57
7
MKC
33
-2
XEL
50
2
AVGO
69
-7
APH
68
-5
CINF
48
3
DOW
38
-2
JCI
33
-2
WRK
65
7
THC
70
-2
KO
49
-3
CPB
40
-2
AEE
37
4
Financhill
Back

Equity Residential Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
65

EQR
Equity Residential

Last Price:
68.30
Seasonality Move:
2.03%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
65
Equity Residential (EQR) is a Buy

Is Equity Residential a Buy, Sell or Hold?

  • The current Equity Residential [EQR] share price is $67.85. The Score for EQR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • EQR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EQR Stock Price Chart

What is Equity Residential's stock price today?

  • The Equity Residential share price today is $67.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EQR is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

EQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 64.94 Buy
Chaikin Money Flow: 1049759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.86 - 67.08) Buy
Bollinger Bands (100): (60.4 - 65.78) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

EQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.59 Buy
20-day SMA: 65.71 Buy
50-day SMA: 65.06 Buy
200-day SMA: 61.08 Buy
8-day EMA: 66.8 Buy
20-day EMA: 66.14 Buy
50-day EMA: 65.12 Buy
200-day EMA: 62.85 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Equity Residential Earnings Growth & EQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.05 per share, and an increase next year of $0.19 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Equity Residential Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):